---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-030817"
form_type: "8-K"
ticker: "PYXS"
cik: "0001782223"
company_name: "Pyxis Oncology, Inc."
filed_at: "2024-03-13T23:59:59+00:00"
generated_at: "2026-06-04T22:27:54.907621+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Pyxis Oncology appoints Santhosh Palani, Ph.D., CFA to board; grant of 69,760 options

## Summary
- Santhosh Palani appointed to Pyxis Oncology board effective March 12, 2024.
- Dr. Palani brings strategic and investment experience from PFM Health Sciences, NEA, and Cowen.
- Received stock options for 69,760 shares at $5.70 exercise price, vesting over 3 years.
- No committee assignments yet; independent director under Nasdaq standards.
- Press release issued March 13, 2024 announcing the appointment.

## SEC filing metadata
- accession: 0000950170-24-030817
- form_type: 8-K
- ticker: PYXS
- cik: 0001782223
- company_name: Pyxis Oncology, Inc.
- filed_at: 2024-03-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1782223/000095017024030817/0000950170-24-030817-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1782223/000095017024030817/pyxs-20240312.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-030817
- JSON: https://secwatch.observer/filing/0000950170-24-030817.json
- Plain text: https://secwatch.observer/filing/0000950170-24-030817.txt

## Key facts
- Executive change
  Santhosh Palani, Ph.D., CFA was appointed as Director at Pyxis Oncology, Inc..
  - Action: appointed
  - Role: Director
  source text: On March 12, 2024, Pyxis Oncology, Inc. (the “Company”), appointed Santhosh Palani, Ph.D., CFA ® , to its Board of Directors (the “Board”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1782223/000095017024030817/0000950170-24-030817-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.